Chapter 73
Drug Therapy of Rheumatoid
Arthritis
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Drugs for Rheumatoid Arthritis
Rheumatoid arthritis (RA)
Autoimmune inflammatory disorder
Treatment
Relieve symptoms
Maintain joint function
Minimize systemic involvement
Delay progression of disease
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
2
Classes of Antiarthritic Drugs
NSAIDs
DMARDs
Nonsteroidal anti-inflammatory drugs
Disease-modifying antirheumatic drugs
Glucocorticoids
Adrenal corticosteroids
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
3
Drug Selection for
Rheumatoid Arthritis
Protocol
Start with NSAIDs
If symptoms persist, add DMARDs
Glucocorticoids may be added until DMARDs take
effect
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
4
DMARDs I: Major
Nonbiologic DMARDs
Methotrexate
Sulfasalazine
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
5
Methotrexate
Most rapid-acting DMARD
Therapeutic effect: 3 to 6 weeks
Adverse effects
Hepatic fibrosis
Bone marrow suppression
GI ulceration
Pneumonitis
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
6
Sulfasalazine
Used to treat inflammatory bowel disease
(IBD); now used for RA as well
Anti-inflammatory and immunomodulatory actions
Can slow progression of joint deterioration
GI side effects may be intolerable
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
7
Other DMARDs I: Major
Nonbiologic DMARDs
Leflunomid (Arava)
Hydroxychloroquine (Plaquenil)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
8
DMARDs II: Major
Biologic DMARDs
Tumor necrosis factor inhibitors
Suppress immune function
Pose risk of serious infection
Work by neutralizing tumor necrosis factor (TNF)
• Etanercept (Enbrel)
• Infliximab (Remicade)
• Adalimumab (Humira)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
9
Etanercept
New DMARD
Use
Inactivates TNF
Moderate to severe RA
Adverse effects
Infection (may be serious)
Injection-site reactions
Tuberculosis
Heart failure
Cancer
Other adverse effects
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
10